Anaptysbio (ANAB) Enterprise Value (2016 - 2026)
Anaptysbio (ANAB) posted Enterprise Value of -$286.5 million for Q1 2026, up 8.08% on a QoQ basis from -$311.6 million in Q4 2025, and up 15.73% year-over-year from -$247.5 million in Q1 2025.
Anaptysbio (ANAB) Enterprise Value (2016 - 2026) Analysis & Trends
Anaptysbio's Enterprise Value history runs 11 years deep, the most recent figure standing at -$286.5 million for Q1 2026.
- Quarterly Enterprise Value rose 15.73% year-over-year to -$286.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$286.5 million (up 15.73% YoY) and the FY2025 annual result came in at -$311.6 million, up 19.13% from the prior year.
- Enterprise Value was -$286.5 million for Q1 2026 at Anaptysbio, up from -$311.6 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$249.0 million in Q3 2025 and bottomed at -$505.6 million in Q1 2022.
- A 5-year average of -$380.6 million and a median of -$390.9 million in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value plunged 33.05% — and 2025, when it soared 42.12%.
- Anaptysbio's Enterprise Value stood at -$441.2 million in 2022, then rose by 11.41% to -$390.9 million in 2023, then advanced by 1.41% to -$385.4 million in 2024, then increased by 19.13% to -$311.6 million in 2025, then grew by 8.08% to -$286.5 million in 2026.
- Business Quant data shows ANAB's Enterprise Value at -$286.5 million in Q1 2026, -$311.6 million in Q4 2025, and -$249.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Anaptysbio | 1.58 Bn | 1.29 Bn | - | -286.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -286.46 Mn |
| Dec 31, 2025 | -311.64 Mn |
| Sep 30, 2025 | -248.96 Mn |
| Jun 30, 2025 | -265.71 Mn |
| Mar 31, 2025 | -339.94 Mn |
| Dec 31, 2024 | -385.37 Mn |
| Sep 30, 2024 | -430.12 Mn |
| Jun 30, 2024 | -350.80 Mn |
| Mar 31, 2024 | -354.67 Mn |
| Dec 31, 2023 | -390.90 Mn |
| Sep 30, 2023 | -413.05 Mn |
| Jun 30, 2023 | -429.49 Mn |
| Mar 31, 2023 | -431.15 Mn |
| Dec 31, 2022 | -441.24 Mn |
| Sep 30, 2022 | -442.97 Mn |
| Jun 30, 2022 | -442.15 Mn |
| Mar 31, 2022 | -505.62 Mn |
| Dec 31, 2021 | -548.10 Mn |
| Sep 30, 2021 | -336.39 Mn |
| Jun 30, 2021 | -332.31 Mn |